– CNBC
FDA Green Lights Cybin’s Psychedelic Clinical Study Assessing Generalized Anxiety
Cybin will advance the clinical development of the novel psychedelic molecule CYB004 for generalized anxiety treatment.
CNBC Halftime Report Final Trades: Seagate Technology, Dollar General & Progressive
– CNBC
Related Posts
Rivian Automotive Receives $827M Incentive Package: What’s Going On With Rivian Stock?
Rivian has received an $827 million incentive package from the State of Illinois Department of Commerce & Economic Opportunity, which will allow the company to expand operations at its plant in Normal, IL. The company said the funds from the incentive package will go towards expansion of the plant, improvements in public infrastructure and job training programs for Rivian's workforce.
SEC Chair Gensler Admits Payment For Order Flow Is Conflict Of Interest: ‘It’s Not A Level Playing Field’ For Retail Traders
SEC Chairman Gary Gensler was asked some hard-hitting questions by podcast host Jon Stewart. Many of the answers centered on Gensler wanting to do the right thing, but being resource constrained. Here’s a summary of the conversation.
SEC Moves To Freeze Binance’s US Assets With Temporary Restraining Order
In a significant development, the U.S. Securities and Exchange Commission is moving to freeze the assets of Binance US as part of its lawsuit against the cryptocurrency exchange.